Benzinga | Nov 6, 2020 05:29AM EST

SVB Leerink Maintains Outperform on Bio-Techne, Raises Price Target to $320

SVB Leerink analyst Puneet Souda maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $285 to $320.